SCHEMBL18023028

SCHEMBL18023028

Cc1cccc(-c2ccc3nc(-c4cccnc4)nc(N(C)C)c3c2)c1F

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 4/20 0.58
▸ CYP2D6 P10635 4/20 0.58
▸ CLK4 Q9HAZ1 4/20 0.58
▸ CYP3A4 P08684 3/20 0.58
▸ CYP2C9 P11712 3/20 0.58
▸ TSHR P16473 3/20 0.58
▸ ALDH1A1 P00352 2/20 0.58
▸ MEN1 O00255 1/20 0.58
▸ GLA P06280 1/20 0.58
▸ KMT2A Q03164 1/20 0.58
▸ MAPK1 P28482 3/20 0.47
▸ LMNA P02545 1/20 0.47
▸ HIF1A Q16665 1/20 0.47
▸ GBA1 P04062 12/20 0.46
▸ ADRB2 P07550 1/20 0.45
▸ CYP2C19 P33261 2/20 0.44
▸ RXFP1 Q9HBX9 1/20 0.43
▸ ABCG2 Q9UNQ0 1/20 0.42
▸ LATS1 O95835 1/20 0.42
▸ LATS2 Q9NRM7 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14727590 0.91 CYP1A2 (0.59) CYP1A2CYP2D6CLK4CYP3A4CYP2C9
SCHEMBL17214441 0.89 CYP1A2 (0.66) CYP1A2CYP2D6CLK4CYP3A4CYP2C9
SCHEMBL14474077 0.86 CYP1A2 (0.65) CYP1A2CYP2D6CLK4CYP3A4CYP2C9
SCHEMBL14475208 0.84 CYP1A2 (0.64) CYP1A2CYP2D6CLK4CYP3A4CYP2C9
SCHEMBL16183550 0.83 CYP1A2 (0.58) CYP1A2CYP2D6CLK4CYP3A4CYP2C9
SCHEMBL14475027 0.82 CYP1A2 (0.65) CYP1A2CYP2D6CLK4CYP3A4CYP2C9
SCHEMBL14727592 0.82 CYP1A2 (0.59) CYP1A2CYP2D6CLK4CYP3A4CYP2C9
SCHEMBL14727535 0.82 CYP1A2 (0.65) CYP1A2CYP2D6CLK4CYP3A4CYP2C9
SCHEMBL20273720 0.80 CYP1A2 (0.57) CYP1A2CYP2D6CLK4CYP3A4CYP2C9
SCHEMBL14475165 0.80 CYP1A2 (0.62) CYP1A2CYP2D6CLK4CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3056207-A1 THERAPEUTIC COMPOUNDS AND RELATED METHODS OF USE Otsuka Pharmaceutical Co., Ltd. (JP) 2016-08-17 — — EP disclosed
Send feedback